Search

everythinglearnresearchcommunity

for

Search:↓

Different types of resting melanocyte stem cells have unique characteristics and vary in their potential to become other cells.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

A group has developed therapies that show promise for treating cancer and various other conditions.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

CD90 is present on specific cells in dog hair follicles.

IL-15 promotes hair growth and protects hair follicles.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

IGF2BP3 and other m6A-related genes are linked to keloid formation and could be potential treatment targets.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

SDF-1/CXCL12 and its receptor CXCR4 are crucial for melanocyte movement in mouse hair follicles.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

IL-1 signaling is crucial for hair follicle stem cell growth and wound healing.

CD133+ cells help heal diabetic ulcers by promoting blood vessel growth and activating Wnt signaling.

Stem cell vesicles reduced eczema symptoms in mice safely.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Myeloid cells can turn into skin and hair cells to help heal wounds.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Fucoidan reduces bone cell formation by affecting T-cell activity.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Targeting specific T cells may help treat alopecia areata.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

CD1d expression in scalp skin and hair follicles changes with the hair cycle and may help protect against microbes.